Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Total Liabilities (Quarterly): 13.76M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.76M |
| June 30, 2024 | 12.20M |
| March 31, 2024 | 10.05M |
| December 31, 2023 | 13.15M |
| September 30, 2023 | 13.26M |
| June 30, 2023 | 15.55M |
| March 31, 2023 | 13.60M |
| December 31, 2022 | 10.08M |
| September 30, 2022 | 8.892M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.644M |
| March 31, 2022 | 7.953M |
| December 31, 2021 | 7.767M |
| September 30, 2021 | 7.734M |
| June 30, 2021 | 6.675M |
| March 31, 2021 | 9.239M |
| December 31, 2020 | 23.70M |
| September 30, 2020 | 42.26M |
| December 31, 2019 | 19.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.675M
Minimum
Jun 2021
42.26M
Maximum
Sep 2020
13.51M
Average
11.14M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Viking Therapeutics Inc | 26.44M |
| Biomarin Pharmaceutical Inc | 1.438B |
| Elite Pharmaceuticals Inc | 40.93M |
| Verrica Pharmaceuticals Inc | 66.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 378.23M |
| Shareholders Equity (Quarterly) | 364.47M |